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SE1HOR THESIS 
THE l.JlENOPAUSE 
With special reference to endocrine therapy. 
Apljil 20, 1933. Harry A. Jakeman 
A discussion of al} phases of the menopause would be practically 
imposei ble in a paper of this nature. Everyone connected with the medical 
profession~ however, is well acquainted with this syndrome and realizes 
the import~mce of its place in the medical curriculum regardless of t:he 
particular line of medic ine in which one may be interested. 
By way of introduction, I will discuss briefly the menopause as to 
etiology I symptomatology, and ccurse, the chief object of this paper being 
that of' therapeuti.cs. 
Tilt, in 1882, was perhaps the first man to write intelligently and 
scientifically upon this subject. His work was published in book form. 
In this publication, he attempted to define the condition as follows: "The 
terms 'climacteria' in Latin; 'climacteric disease', 'change of life', 
'critical time', 'turn of life', in English; 'temps critique', 'a~e de 
retour', am 'menopause T J in French; and 'aufhoren der weiblichen reinigung' 
in German; .are understood to mean a certain period of time, beginning with 
those irregularities which precede the last appearance of the menstrual 
flow, and ending with the resettlement of health". 
Tilt recognized the fact that this phenomenon was, in all probability, 
dUG ,,0 ovarian changes and he called attenti'On to the atrophied condition 
of the reproduction systeril of Vliomen going througtl this change. Tilt says, 
"While involution is taking place, the 'Ovaries disturb the viscera, with 
which they have worked harmoniously for thirty years". At that time, the 
nature of the disturbance was not known but was thought to be similar to 
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that made l11an ifest by the coming into power of the ovaries at puberty, 
because the s;Ylr,ptOIIJB at both periods of life are very siIr.ilar. 
Treatmerrb at this tilne consisted chiefly of sedation and general 
oonstitutional measures - baths~ etc. Bromides were used by Tilt with a 
fair degree of suocess. Bleeding was also done 1!f many practitioners at 
this time. 
Some fifteen years later, Currier publi~<ed ~' J..l~S 1)10 rk OIl the menopause. 
In this "WOrk Currier states, I'For many centuries, the importance of the 
menstrua.l function in women has been a recog:n.ized fact among critical 
observers. Its significance has of course, been differently interpreted 
by observers in different ages and in different conditions of intellectual 
development. Among the crude, the barbarous, and the superstitious, the 
solution of such a problem would not be one vmich would be universally 
satisfactory. Even among higply developed nations, like th~t of the 
Greeks" the interpretation could not be expected to co nform to the facts 
because of imperfect knowledge in physiology and anatomy". 
The Egyptians, who investigated sO many matters concerning the 
human body, realized that menstruation was an importent funotion. This is 
shown irl the books of Moses, much infonne.tion of which was derived from 
Egyptian scurces, and in which a menstruating woman was decle.red cere-
monially unclean, coitus 1'II-i th her beirg forbidden. But Wli1e the 
importance of menstruation was quite generally recognized among the 
more acute of the ancient observers, it was not so with the menopause. 
By some it was passed over as a matter occult and inexplioable, and, in 
general, it failed to receive that broad and philosophic treatment with 
't\rhich so many questions were discussed by the ancients. 
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Currier defined the menopause as the condition which exists and 
the collecti~ phenomena which appear in conneotion with the cessation 
of menstruation. This cessation takes place gradually in most cases, the 
intervals between the menses lengthening, and the latter finally failing 
altogether, after a period from one to three cr four years. During this 
time, the phenomena are varied in character. With some women there is 
scarcely any consciousness that anything unusual is occurring aside from 
the fact that the inter-menstrual intervals are longer than usual. With 
other iIIIomen, the hemorrhages, if less frequent, are much more profuse. 
The nervous system may be unaffected or there may be disturbance of both 
cerebro spinal and sympathettc systems. Vasomotor disturbances are 
extremely common, and mental disturbances are by no means rare. In cases 
in whioh there is predisposition to the development of new growths, such 
growths may develop at this' time • 
Atrophio changes take place in all the genital organs as the meno-
pause progresses. 
Finally, the menopause may be as uneventful as any of the other 
necessary exper iences to whioh the femal e economy is subjected, but it is 
also susceptible to variation as far as possible in the opposite direction. 
While Tilt considered the menopause as a serious, critical time in 
a woman's life, Currier 'W!':l.S prone to consider it a normal, physiological 
process through which every normal female must pass. In fact, nearly all 
writers at this th~e were beginning to become more conservative as to their 
ideas regarding the menopause. 
Treatment of the menopause as outlined by Currier, shows very little 
improvement or advance as compared with that ef Tilt. Currier's outline 
consisted chiefly of' sedatives I bleeding to relieve congested organs, and 
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curettage. In conclusion, Currier says, "There is little additional 
which can be said in regard to the general treatment of those who are 
passing through the menopause. Those who are not sick, but think they 
are, must be disillusioned with gentleness but fi rmness. They must be 
assured that the process is a physiological one through which the great 
majority of women pass unharmed; and yet the unusu~l sensitiveness of 
both body and mind at this juncture must be fully recognized and proper 
caution enforced against all means which could destroy the sensitive 
equilibrium. Those who are sick must be treated upon rational principles, 
not by superstition or tradition. Surgical conditions should be recog-
nized promptly and promptly treated and those "'ho are susceptible to 
relief by drugs should receive remedies which are trie~ and reliable, 
not the nostrums and cure-aIls of the quacks It. 
In 1921, Emil Novak published his work on the disorders of 
menstruation in which he imcluded a detailed aiscussion of the menopause. 
The advance between the time of Currier and Novak is remarkable. Novak 
regards the menopause as marking the termination of the reproductive 
stage of a WOffian's life, tl1e most prominent clinical manifestation of 
this transitio.."1 period being the cessation of the menstrual flow. 
In Novak's experience, he found that more women ceased to menstruate 
between the ages of 45 and 50 than between the ages of 40 and 45, the 
average being about 47 years. 
Speaking generally, it seems to be true that the earlier the 
menstrual :f\mction is established, the longer it will continue. In other 
words, if puberty occurs at an early age, the menopause is likely to be 
late in its appearance, the reverse being, equally true. 
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According to Sanes, the climacterium is usually late in the case 
of women who have led an active sexual life, especially if they have given 
birth to a number of children. On the other hand, it is likely to occur 
early in unmarried ViOmen. 
As a rule, the menopause occurs earl ier' in the women of cold 
climates than in those of the tropics. 
An unusually early or unusually late menopause is said to be noted 
in certain families as a hereditary trait. Examples of such families are 
cited by Currier and others. 
The menopause, as a general rule, occurs earlier in poor, hardworking 
women than in those living in idleness. 
The menopause is frequently seen at an early age in stout women. 
Cases of this type are now looked upon as due to a deficiency of the 
pituitary secretion. The two most prominent symptoms encountered in 
these cases are obesity and sexual hypoplasia, manifesting itself in the 
woman as scanty menstruation or an actual cessation of the process. 
General diseases ass ociated with wasting and general debility tend 
to bring about an earlier menopause than usual, the cessation of the 
funct;ion in such cases being apparently an effort on the part of nature 
to conserve the strength 0 f the woman. 
In the great majority of cases, the effect of local disease in 
the pelvis is to delBythe occurence of the menopause. 
Tilt has published a very interesting ta.ble as to the approximate 
age at ymich there is a cessa.tion of menstruation. I shall include it 




Age of cessation Paris London London Total cases 
B. De Boism.ont's Guyts Tilt's --------------------eases _____________ cases ______ cases ________________________ 
21st year 2 2 
22nd " 1 1 
25th ff 
26th It 1 1 
27th tI 1 1 1 3 
28th It 1 1 2 
29th II 1 1 
30th If 1 10 11 
31st tI 3 1 4 
32nd II 2 4 6 
33rd It 2 1 3 
34th II 4 1 2 7 
35th tl 6 3 6 15 
36th II 7 1 2 10 
37th " 4 5 '7 16 
38th " 7 5 6 18 
39th II 1 7 10 18 
40th It 18 33 42 93 
41st " 10 24 17 51 
42nd " 7 24 26 57 
43rd II 4 23 24 51 
44th " 13 24 23 60 
45th II 13 45 49 107 
46th If 49 34 31 74 
47th " 13 25 42 eo 
48th It 8 38 37 83 
49th II '1 25 32 64 
50th tt 12 37 49 98 
51st It 4 14 27 45 
52nd " 8 13 16 'Sf 
53rd tt 2 8 9 19 
54th It 5 2 7 14 
55th It 2 1 6 9 
56th It 2 2 4- 8 
57th fI 2 1 2 5 
58th ft 4 4 
59th " 1 1 
60th tI 1 ... 1 2 
51st It 2 2 
Total 181 ~- 400 5m-- lO82-
Average age of cessation (1082 cases) - 45 years 9 months. The 
average duration of the menstrual fu.nction was found to be 28.95 years 
by B. de Boisntont, and 31,33 years by Tilt. 
7 
There are marked individual variations in the duration of the 
menopausal perieXi. It must be borne in mind that the cessation of the 
menstrual function is only one# though perhaps the most striking, of a 
whole group of changes which mark the retrogression of the reproductive 
function. Properly speaking, the menopause embraces all these various 
phenomena and from this viewpoint, its duration is from a few months to 
several years. The average duration may be placed at from two to two and 
one-half years according to Novak. 
As the woman approaches the climacteric age, even while the 
menstrual function is still regular, she is likely to experience more 
or less of the vasomotor disturbance "J'Jhich, next to the disappearance 
of the menses, is the most important manifestation of the menopause. 
From time to time, there will be an intense though transitory flushing 
of the head and neck, accompanied by a sensation of flashing heat. This 
is frequently followed by sweating, sometimes copious. The temperament 
of the woman is quite likely to undergo some change though only excep-
tionally, is this very profound. Usually this change is evidenced only 
by unusua.l nervousness, irritabilitYII and peevishness. By thi.s time, 
there has probably been more or less disturbance of the menstrual rhythm. 
Whereas the menses have been recurring at regular £our week intervals, 
and have been lasting perhaps four or five days, they now become usually 
more scanty, }a,st:i.ng only a day or two. There may be even a complete 
skipping of one period. This may be followed by sca..nty menstruation for 
a month or two, and then will come another period of amenorrhea. In this 
gradual manner, the menstrual function tapers off into complete disappearance. 
The vasomotor symptoms usually continue for a longer or shorter time after 
the cessation of menstruation, their disappearance also being gradual 
as a general rule. In the majority of cases, there is a tendency to 
laying on of adipose tissue, sometimes amounting to an actual obesity. 
This is the typical course .of the menopause. However, the symptoms 
may be so slight as to be scarcely noticeable and in other cases, they 
m2.y be very severe. As before, it is stated that the duration of the 
symptoms varies greatly. The psychic changes may go on to insanity 
thouGh rarely is this true. 
All the anatomic changes demonstrable in various organs at the meno-
pause are L~dicative of the universal retrogression which characterizes 
this period. Marked atrophic changes are seen in the tissues of the 
vulva. The fat of which the labia are so largely composed disappears 
almost entirely, so that they become little more than two long skin folds. 
The clitoris becomes very small. As a result of the so-called senile 
atrophy, with its attendant thinning of the epithelial layer, the mucous 
membrane of the vulva loses its velvety, vascular appearance, and becomes 
thin, pale, and transparent looking, giving the surface a rather pasty 
appearance. The vagina becomes narrow and contracted, the result of the 
same process of senile atrophy in which there is a replacement of paren-
chymatous by interstitial tissue. The va.ginal mucosa like that of the 
vulva, becomes thin and atrophic. The cervix becomes very small and 
short. The uterus also becomes very small and hard, the endometrium 
becomes thin and avascular. The fallopian tubes also participate in the 
retrogressive processes of the menopause, becoming shorter and thinner. 
The fim.briae disappear or becorr.e very inconspicuous as do also the 
longitudinal rugae in the mucosa. The size of the ovary is much changed 
in the maj ority of cases. The surface is not glistening as in the case 
of the young woman, being now of an opaquely white appearance. The 
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peculiar wrinkling at this time resembles the surface of a peach stone. 
The mammary glands also becane small and atrophic in the majorit'lJ of 
cases. 
With the foregoing discussion serving to introduce the menopause in 
general, a more detailed dis cuesion of therapeutic measures iNil1 be 
attempted in the following pages. 
The higher the standard of general health and resistance with which 
the woman enters upon the menopause, the better her clu'lnce of passing 
through it with a minimum of discomfort. It is scarcely necessary to 
discuss at any length the importance of such factors as care in diet, 
proper sleep. bathing, avoidance of constipation, and especially, the 
avoidance of worry and anxiety of any sort. Strict insistence by the 
physician on the carrying out of these measures and an intelligent 
cooperation on the part of the patient, will do much to relieve the 
suffering of the woman who is passing through' this trying period. 
The wcman Vlho approaches the menopause in good physical health is 
muoh less likely to suffer severe disturbances than the one who arrives 
at this period worn out by physical disease, ID&l.Y child births, domestic 
oares J anxieties, and other such caus as. Of special importance is the 
avoidance of worry and anxiety, The brunt of the menopausal storm seems 
to fall upon the WOI:1m"!.' S nervous sys tem and this should be spared in 
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every possible way. Members of her f81nily should be urged to show her 
every consideration in this trying period whenever pronounced temperamental 
c~anges me,y make theD',selves apparent. 
Drugs are almost always neoessary in addition. Of' sedative drugs, 
those in most common use are opium by mouth, and the bromides, pheno-
barbital and similar drugs. To secure sleep, it is a]most always necessary 
10 
to give s orne hypnotic such as barbital, medinal $ sulphonal, chloral, or 
paraldehyde. Sometimes alcohol at bedtime will secure sleep. In the 
majority of cases, Eliy.ir triple bromide will give very good results -
the dosage depending upon the severity of symptoms. 
The most recent adV13-12CeS in therapeutics have been made along the lines 
of endocrinology, the results in some cases having been gratifying and in 
others, very disappointing. 
The ova de s have a twofold functi on. First~ -they have an excretory 
function of producing and discharging ova, and second, an incretory function 
of regulating the growth and maintaining the function of the genital organs. 
In 1827, Von Baer demonstrated the mechanism of ovulation, and for long 
after, it was believed that the stimulation of this process accounted for 
those phenomena that are now known to be the resu It of internal secretions. 
The present knowledge of the physiology of the famal e reproducti va 
organs was initiated by :Knauer who, in 189B, showed in experimental 
animals, that transplantation of ovaries prevents the usual atrophy of 
the uterus that follows ovarian extirpation. This experiment proved that 
the ovaries must produce an internal secretion which, acting through the 
medium of the blood, preserves the integrity of the genital organs. Knauer f s 
conclusions were immediately verified by other investigators (Grigorieff, 
Ribbert, and Rubinstein). In the year 1900, Halban added a new and 
important phase to the sUb.ject by sho'wing that if an iF-mature female 
guinea-pig is castrated and an ovary transplanted subcutaneously, normal 
puberty occurs. This proved that the ovaries produce an internal secretion 
that governs the anatomical and physiological development of genita 1 
organs, and a.lso for the atrophy with ovarian dysfunction at the menopause. 
Clinical attempts !:l.t substitution therapy were ID!lde by a~ministerir.g 
ovarian extracts for all kinds of menstrual di Borders but w'i th little 
success - a failure which has clouded the career of ovarian hormonology 
up to the present time. But the result of anirpal exper mentation with 
these same extracts has been a different and remarkable story. 
Adler in 1912 was the first to produce segual activity in ovariec-
tionized animals by the injection 0 f watery extracts of ovary. Adler I s 
work marks the turning point in the history of the seareh for the ovarian 
hormone. 
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Most people thought of the internal secretion of the ovary as a single 
substs.nce but were perplexed at the multifarious and contradictory fUYlcti ons 
of which it ",vas capable. 
The final triumph of the female sex hormone came in 1928 "When Allen and 
Doisy in this country, and a few months later Butenarrlt in Germany, 
announced the isolation of the hormone in crystalline form from the 
follicle. 
But there were als 0 many doubters who still bel iev-ed that the oorpus 
luteum must elaborate a specific hormone entirely distinct from that of 
the follicle liquid. Corner, in 1929, settled this question beyong dispute 
when he isolated the corpus luteum hormone which he called "progestin If. 
The relationship of theelin and progestin will be discussed later. 
Allen and Daisy identified the follicular extract by the changes it 
produced in the uterine and vaginal epithelium of rodents. The extract 
was also standardized by this means. The vaginal smear from a ra.t' s vagina 
at rest or atrophied from castration consists chiefly of leukocytes. Under 
the influence of natural or artificial oestrous, the smear shows great 
numbers of non-nucleated squamous epithelium. The rat unit as defined by 
,-
them is the Ithighest dilution of an extract which, when given to a mature 
spayed rat in three injections at four hour intervals during the first day, 
will result in cornification and desquamation of vagina:;, epj;thelium on the 
morning of the third day". 
Corner established a test for the corpus luteum secretion similar in 
nature to that used for tho tollicular secretion. The experiment was 
carried out as follows: A doe rabbit is mated and eighteen hours later 
is subjected to removal or both ovaries and the exoision of a small portion 
of the uterus. Corpus lute~~ extract is administered for five days and on 
the sixth day after mating, the animal is killed, the embryo recovered if' 
present, and the uterus submitted to histologic examination and comparison 
with the specimen removed at the time of castration. Under the influence 
of the extract, the uterus undergoe s the character istic progestational 
ch8.nges. To the eye and under the microscope, the 00 :n:'l.i tion 9f such a 
uterus csn in no way be distinguished from that of normal pregnancy of the 
fifth or sixth day except that a.fter large doses, the proliferation may be 
even greater than in normal pregnancy. 
The same experiment was perfor-reed using folliculin ~theelin) instead 
of progestin, but nons of the progestational changes could be produced. 
The syrlergistic relationship between the fo11ic Ie and corpus luteum 
has been demonstrated by a number of striking experiments. 
Corner and Hartman, working separately on the sex cycle of menstruating 
monkeys, both found that these primates sometimes menstruate in regular 
course without any precedi ng ovulation or corpus luteum formation in the 
ovaries. The endometrium in such cases doe s not show the pre-menstrual 
changes typical of true menstruation folloVc~ng ovulation. They the~efore 
concluded th..at in primates at least, there are tv~ types of menstruation, 
one where there is ovulation, and a pre-menstrual grmrth of endometrium 
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and one ~fuere these changes are absent. They then injected theelin into 
castrated monJ;:eys and produced menstruation, but without the pre-menstrual 
proliferation of the mucosa. Corner. and also Hisa"1lJ, next tried sensitizing 
the mucosa by injections of theelin and then following this ~~th a series 
of injections of progestin. After this double treatrrcent, true menstruation 
ensued with characteristic pre-menstrual proliferation of the mucosa. 
FraIn this experiment, -chey reasoned that the function of the follicular 
hormone seems to be that of putting the uterus in the proper physiological 
condition so it can respond to the corpus luteum hormone. Neither of these 
substances can produce progestational proliferation in the castrate uterus 
when given alone. If, however, it is first brought into condition typical 
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of oestrus through the injection of follicular hormone, and is followed 
immediately by corpus 1uteum treatment, progestational proliferation results. 
We ceme now to a relationship between the internal secretions of the 
ovary and those of the hypophysis. Knowledge that such a relationship 
exists dates back to 1901 when Frelich described his famous syndrome of 
hypo-pituitarism, adiposogenital dystrophy. and hypo-sexualism. 
Later experiments by Zondek and Asohheim proved that by transplanting 
a fresh piece of anterior lobe in an infantile mouse, a condition of oestrus 
was invariably brought about. 
On the other hand, anter ior lobe transplantation has no efFect on 
the vagi:..YJ.B. and uterus of an ovariectomized animal. In a normal animal, it 
causes oestrus and also ovulati on and luteinization in the ovaries. 
It was soon found that tl'O substances were conta.ined in this pituitary 
extract as the same result was not always obtained. The two substances were 
isolated - chiefly by Zondek and 1}lrere called Prolan A and Prolan B, Prolan A 
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being a follicular ripening hormone and Prolan B a luteinizing hormone. 
Zondek also holds that there are two other substances contained in the 
anterior lobe, and summarizes the situation a's follows: 
1. Growth hormone 
2. Prolan A follicular ripening hormone. 
PItOLAN 
3. Prolan B luteinizinl! hormone. <.' 
4. Metabolism hormone. 
Zondek, after making this discovery, correlated the pituitary hormones 
wi th thase of the ovary as fol101liTs: 
1. The female sexual function manifests itself in the fol1crwing 11Iray: 
the anterior lobe of the hypophysis is the motor of the sexual function and 
the hormones of the anterior lobe are the superordinated specific hormones 
,-' of sex. 
2. Prolan A sets off follicle ripening and incites the theca cells 
of the follicle to the production of folliculin which in turn induces the 
proliferative phase of the endometrium. 
3. Prolan B effects the chan ga of the granulosa and theca cell 5 to 
lutein cell sand inoi tea in them the production of pro gestin which. changes 
the proliferative phase of the endometritun to one of secretion (pre-menstrual, 
pregravid, pregestational stage.) 
Correlation of the hormones of the hypophysis and the ovary are 
very wall illustrated in Zondek's diagram, appearing in Gravers work on 




1l'iJ I; ray<.1 i it'~ 
5taf'fe 1i\(1.m~nstl"u ~, 
5iJ~It. 
Prolan A, starting from the hypophysis stimulates the growing: 
follicle to the produntion stage of folliculin which" in turn, stimu~ates 
the proliferative stage of't'he endometrium. A small run.ount of folliculin 
is excited in the corIUs luteum as irrlicated by the broken line. Prolan B 
sti~~lates the lutein cells of the corpus luteum to the production of' 
progestin. The hypophysis also elaborates the special' growth hormone and 
a probable metabolic hormone. 
15 
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Frank found that the urine and serum of women eoing through 
the menopause, contained little or none of the female sex hor-
mone using the vaginal smear test of Allen and Doisy. 
:Bearing in mind the foregoing facts, the cliniccl.1 app-
lication of these extracts will be discussed. 
The premise that menopause symptoms are associated with 
a cessation of ovarian function is both reasonable and logical. 
As a cor,ollary, it may be stated that the loss of the dominent 
ovarian secretion - the female sex hormone would appear to be 
a most important factor, although the increase in pituitary 
hormone must be taken into account. On this basis, attempts 
to replace this loss of female sex hormone by a substitution 
therapy are surely indicated. 
Since so many hormones have been identified and described 
it is unreasonable to believe that anyone hormone alone can 
be responsible for the symptoms encountered in the menopause. 
It will be necessary as pointed out by Frank and others, to 
analyze chemically or by other means, and to determine in just 
what hormone or hormones we are lacking, and to substitute 
a.ccordingly. 
According to Frank, in addition to the usual clinical ex-
aminations, which in those cases which are worked up, include 
a careful history, anthropometric measurements, basal metabol-
ism, differential blood count, and, when indicated, sugar 
tolerance, seller roentgen and visual field examinations, 
certain hormone tests should be performed. 
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The hormone tests which Frank advocates in properly select-
ed instances include "the evaluation of the female sex hormone 
blood level thruout a cycle, or, if no periodicity exists, 
over a. period of from five to six weeks, with simultaneous de-
termination of the hormone excretion through the urine. Tests 
for the prepituitary hormone have been studied, but thus far 
no satisfactory results have been obtained. The tecnics for 
the female sex hormone are now sufficiently standardized to 
permit the study of a considerable number of cases each month 
in small laboratories not pessessing special equipment. 
The treatment of menopausal symptoms has yielded varying 
results in the hands of different gynecologists. Kurzok offers 
an explanation for this in his paper on "Follicular hormone in 
the urine as an index of therapy in the menopause." Kurzok 
found that those patients who are not benefited by ovarian 
therapy have ovarian hormone in the urine while those that are 
benefited have none. Kurzok has determined that every normal 
woman during her active sex life excretes from ten to twenty 
rat units of follicular hormone per liter of urine. This level 
of excretion is fairly constant, though there are minor varia-
tions within these limits during the menstrual cycle. 
Kurzok has grouped, cases of m~nopause as follows: 
(1) No ovarian hormone found in urine. 
(a) Artificial menopause (x'ray or operation) 
(b) Some cases of spontaneous menopause. 
(2) Ovarian hormone present in the urine. 
(a) Some cases of spontaneous menopause. 
The subjects that show no ovarian hormone in the urine 
.. ~ 
18 
are very distinctly benefited by therapeutic injection of the 
hormone, while those that show ovarian hormone in the urine are 
not at all benefited by the treatment. When both ovaries have 
been removed at operation or when sterilization due to radiation 
is complete, no follicular hormone is to be f~und in the urine. 
In the spontaneous menopause group the subjects that menstruate 
normally and have menopausal symptoms, ovarian hormone is al-
ways found inthe urine, and the administration of more ovarian 
hormone is of no benefit. 'Vhen the patient menstruates in-
frequently and the excretion of ovarian hormone is sporadic, then 
follicular hormone is beneficial. In subjects that are not men-
struating, follicular hormone mayor may not be found in the 
urine; it is only in the latter group that good results are ob-
tained. 
All cases of menopausal symptoms are investigated and treated 
in .the following way: A twenty-four hour specimen of urine is 
collected from 7a.m. to ?a.m. The ur.ine collected at ?a.m., At 
the end of the 24 hours is kept in a separate bottle. The 
larger quantity of urine collected on the previous day is sub-
jected to a quantitative follicular hormone determination. The 
separate morning specimen is tested for the presence of gonadal 
stimulating hormone, prolan A, by the method of Zondek. When 
ovarian function has ceased the findings are as follow. : Ov-
arian hormone, negative; prolan A, positive. Zonkek has shown 
that when the ovaries cease functioning prolan A immediately 
appears in the urine. On the other hand, if the ovaries are 
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functioning ovarian hormone is found in the urine and prolan A is 
absent. Only when there is no ovarian hormone in the urine 
according to Kurzok is theelin indicated as a therapeutic meas-
ure. There is apparently no reason for injecting ovarian hor-
mone when the patient is already excreting considerable quan-
tities of the hormone in her urine. 
Kurzok treats patients having hormone in the urine by me-
ans of triple bromides and calcium lactate, the purpose being 
to depress the irritability of the vasomotor and the other cen-
ters involved. 
Theelin has been given orally to women, whose urines were 
followed for its excretion over a period of one or two months. 
Eight cases are reported by G.V. and O.W. Smith, which includes 
four amenorrheic patients, three sterile and one normal c;ontrol. 
The results would indicate that in women as in rabbits theelin 
is excreted only when the organism has been exposed to the 
action of corpus luteum. It appears possible by this means to 
differentiate between a persistent corpus luteum, irregular 
appearance or total absence of corpus luteum, and cyclic activ-
ity of the corpus luteum. 
In Kincaid's experience there are two types of patients 
who may be benefited by ovarian therapy: The sterile woman 
who has not conceived, apparently because of the lack of suff-
icient ovarian hormone, and the woman suffering from the sympt-
oms so often seen at the beginning of the menopause. 
Kincaid reports three cases of menopause occurring pre-
maturely in which he used theelin in massive doses(lOO rat units 
a day for 6 days). Gratifying results were had in all three cases. 
Two objections are generally raised regarding the hypo-
dermic use of theelin: first, the need to use a needle and the 
necessity of monthly repetition. A third objection can be 
raised, namely, the cost of the preparation which, judged by 
usua.l drug prices, is high. The patients generally feel however 
that the injections are worth the cost, and readilly submit to 
monthly injections when necessary. The local reaction from hypo-
dermic injection has been found to be very slight in amount, 
and not contraindicative to its use. 
Kincaid closes his paper with this statement: "It seems 
from my experience, that any woman is entitled to a tria.l of 
treatment with follicular hormone, who presents her self to her 
physician, giving a clear cut history of diminishing menses acc-
ompanied with subjective symptoms of the menopause, in the ab-
sence of any other demonstrable pathologic conditton. 
Definite conclusions cannot be drawn from three cases, but 
it is further testimony that ovarian therapy is meeting with 
a certain degree of success. 
King of Johns Hopkins has published a paper in which he 
attempts to compare the therapeutic effect of ovarian therapy 
with tha.t of bromides and pheno barbital. The results were re-
corded as follows: If symptoms disappeared entirely under treat-
ment the result was expressed as "plus 106;11 if the symptoms 
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were much improved as "plus 75;" improved substantially "plus 
50;" slightly improved, "plus 25;" If 'symptoms became much 
worse under treatment the result was entered as "minus 100;" 
rather severe exacerbation of' symptoms was called "minus 75;" 
less severe "minus 50;" slightly worse under treatment "minus 
25." 
Phenobarbital was used essentially to control the results 
of ovarian treatment, its use justified by the vasomotor and 
neurogenic nature of menopause symptoms. Phenobarbital gave 
somewhat better res't,llts (plus 33.7 per cent) than those obtain-
ed from ovarian substances as nearly as could be estimated. 
In a smaller number of observations (eleven) there was no 
exacerbation of symptoms under bramide therapy. This group 
claimed the greatest degree of improvement (p1us47.7 per cent) 
However, the number of cases in this group is smaller than 
those in the other groups except the follicular extract group, 
which also contains eleven observations. 
In the corpus luteum group 28 observations were made on 
17 different patients. A standard preparation was given by 
mouth in the usual dose ( one 5 grain tablet t.i.d.) or in 
double the usual dose. The results show an average improve-
men't of 19.6 per cent, which is not so good as the results 
with phenobarbital or bromides. 
Whole ovary ( 5 grain tablets t.i.d. ) showed improvement 
of 22 per cent in twenty five observations. 
Follicular extract 5 to 25 rat units daily was used in 
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a group of eleven patients in this series, the beneficial result 
was estimated as "plus 9.1 per cent." 
Corpus luteum increased the basal metabolic rate 3.1 per 
cent, whole ovary produced no change. The follicular extract 
decreased the basal metabolic rate 3.6 per cent. 
From these results the following conclusions were drawn: 
1. Corpus luteum and whole ovary by mouth and follicular 
extract subcutaneously are probably useless in the relief of 
symptoms of the menopause. 
2. Bromide or phenobarbital or a combination of the two 
is distinctly helpful in the treatment of such symptoms, pro-
bably not specifically but as general mild sedatives. 
3. Corpus luteum may raise a low metabolic rate in a 
patient at the menopause, but this effect is not suffiCiently 
striking or constant to warrent definite conclusions. Fresh 
whole gland and follicular extract seemed to have no significant 
effect on basal metabolism. 
Before considering the foregOing conclusions too seriously 
it must be borne in mind that this work was completed in 1928 t 
much advance has been made since that time. I do not believe 
that doses of follicular extract ranging from 5 to 25 ·rat units 
daily are sufficient to draw any conclusions. As will be po-
inted out later doses of follicular extract consisting of 100 
rat units daily have been given with gratifying results. Further-
more it has been definitel.y shown by research workers in the 
past few years that the older commercial preparations of corpus 
luteum and whole ovary had very little or no potency. This fact 
has been generally recognized by gynecologists thruout the co-
untry and has led to a closer union between the clinician and 
research worker, I shall refer to these results later in this 
paper. 
The effect an the basal metabolic rate is significant, and 
prooves only further the interrelationship of the endocrine 
system. 
As pointed out by Schoeller, Dohrn and Hohlweg animal ex-
periments have clearly shown that the complete developement 
of female characteristics in an individual is only to be expect-
ed when the follicular hormone is produced in adequate amounts. 
Follicular hormone therapy is therefore, justifiable in all 
cases due to ovarian hypofunction. 
Climacteric changes form the chief indication for follicul-
ar hormone therapy, and it will also favorably influence con-
ditions due to partial or complete artificial suppression of 
ovarian function. 
In this connection the relief of vasomotor disturbances, 
which form a frequent and distressing SjEptom, is most import-
ant. The symptom complex is not, however, confined to the 
cardia vascular system. Cutaneous manifestations such as prur-
itus and eczema, intestinal symptoms in the form. of severe con-
stipation, arthritic conditions Which are refractory to anti-
rheumatic treatment, are all met with and form a most faTor-
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able field for substitution therapy with the follicular hormone, 
mental changes, especially the frequently occuring psychic de-
pression, are also benefited. Here the generalized tonic eff-
ect of the follicular hormone undoubtedly plays an important 
part since, in addition to readjusting local disturbances, it 
produces a condition of euphoria which is in full harmony with 
the somatic regeneration which sueeessful hormone treatment pro-
duces in women. This general rejuvenation has also been ob-
served in elderly women in whom the climacteric symptoms have 
already subsided. 
In contrast to the results reported by King, I shall pre-
sent 25 cases reported by Geist .and Spielman of New York. Thee-
lin was used in all cases. Theelin represents the purest pro-
duct obtainable, and assays as labelled, 50 rat units per c.c. 
The preparation was administered by intramuseular inject-
ion in increasing doses beginning with 50 rat units three times 
weekly. The patients were always carefully interviewed regard-
ing the effects of injections in regard to exacerbation or im-
provement of symptoms. Before treatment complete physical ex-
aminations, blood pressure readings, complete blood counts, bas-
al:~.metabolism, x'rays of sella turcica and joints when indicated, 
and weight were recorded. The symptoms which were stressed and 
which were usually present were hot flushes, sweats, headache, 
joint pains, insomnia, palpitation, libido, paresthesias, and 
psychic disturbances. The majority were observed and treated 
from four to eighteen weeks. 
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The results were as follows: Four of the twenty five cas-
es were markedly improve.d, eight were slightly improved, in 
eight there was no improvement at all and in three there was 
improvement with bleeding. 
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The eight cases reported as slightly if at all improved 
are of little value. For the sake of accuracy they have to be 
designated as improved. As far as improvement in the individual 
symptom is concerned, it was found that the joint pains were 
almost never improved, headaches rarely, sweats only with improve-
ments in flushes; palpitation, paresthesias, and insomnia were 
improved more often. 
It is interesting to note that the natural menopause app-
ears more amenable to treatment than the artificial of the 14 
cases treated eleven were improved, seven markedly so. Here also 
it was observed that in three' of these cases the menstrual per-
iods were reestablished with complete alleviation of symptoms. 
In later case reports we shall see however, that much succ-
ess has been had in the treatment of artificial menopausal 
symptoms, it is apparently a question of dosage. 
In order to illustrate just how these cases were man-
aged, I shall present the cases reported by Geist and Speilman. 
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Case 1. A. S. aged fifty, married, natural menopause, Aug 
1928. Symptoms were as follows: Flushes 20-30 per day, aCCOM-
panied by sweats, headaches present for fifteen years, worse' 
since menopause. Joint pains also present for fifteen to twenty 
years. Physical examination negative. Blood pressure 135/105 
Weight 150. Urinanalysis essentially negative. B.I.R. negative. 
Blood count showed hemoglovin 65 per cent. and lymphocytes, 52 
per cent, otherwise normal. She was treated with sedatives, at 
first, then thyroid with impDovement. She received 14 inject-
ions of theelin, from February 19 until Mar 12, 1931, in increas-
ing doses up to 150 rat units per injection. There was slight 
improvement. 
Case 2. E. B. Aged forty three, married natural menopause 
Jan, 1930. Complained of flushes 1-2 per day, sweats not marked, 
headaches, ,j oint pains, occasional insomnia. Physical examin-
ation except for a blotchy skin with acne was essentially neg. 
B.P. 136/80. Blood count normal. B.Y.R. minus 3 per cent. 
Urinanalysis neg. She received 166 rat units per injection. 
She stated that she felt better, but origional symptoms were 
very mild. 
Case 3. E. G. Aged thirty-eight, married, natural menopa-
use Dec 15 1931. This patient complained of three flushes per 
day, occassional headaches, joint pain in left shoulder, pres-
ent before cessation of menses. Slight palpitation, psychic 
disturbances, insomnia. Libido present. Physical examination 
negative. B.M.R. minus 4 per cent. Blood count normal. B.P. 
normal. She received 14 injections from Mar 3 until May 25, 
1931. There was slight improvement in symptoms, which were 
origionally mild. 
Case 4. A. S. Aged 47, married, weight 147, natural meno-
pause, Jan 30, 1931. Symptoms appeared Sept, 1930. Flushes 
every half hour, sweats, headaches, joint pain in right shoulder, 
palpitation, marked insomnia, libido absent. Physical examin-
ation essentially negative. B.P. 142/78. B.M.R. minus 21 per 
cent. Urinanalysis neg. Theelin was begun April 18, 1931 and 
was continued until April 27, 1931, she received 6 injections 
with slight improvement. In view of the B.M.R. minus 21 per 
cent, she was placed on thyroid gr 1/4 t.i.d. 
Case 5. R. L. Aged 47, married natural menopause Aprll 
1930. Symptoms began about that time. They included flushes, 
profuse sweats, headaches pain in left knee, psychic disturb-
ances and insomnia. Blood count and basal metabolism were not 
done. Physical examination negative. Patient still has occas-
ional periods of bleeding. She received theelin from April 27, 
1931 to June 8, 1931, receiving 9 injections up to 250 rat units 
per injection. She improved so that all symptoms disappeared 
except the j oint pain. 'She then bled from :May 23 to :May 26. 
When seen subsequently, she was having only 2 mild flushes per 
day. In this case the improvement associated with the bleeding 
was so marked that further treatment was stopped. 
Case 6. R. R. Aged 43, married, natural menopause Feb 
15, 1931. Symptoms immediately after this inoluding frequent 
flushes, severe headaches, joint pains inelbow and palpitiation, 
and insomnia. Physical examination essentially negative. B.P. 
165/100. Weight 191. B.M.R. minus 25 per cent. Complete blood 
count normal exoept for eosinophiles of 5%. She received thee-
lin from June 8 until Aug 20, three times a week, 9 injections 
all together up to 300 rat units per injection. Symptoms were 
mild. Under treatment they completely disappeared according to 
her statement at the last examination. This patient was very 
cooperative and very grateful for the treatment received. This 
probably influenced improvement considerably. 
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Case 7. A. K. aged 42, married, natural menopause five 
years ago. Complaired of flushes every half hour, sweats, back-
ache, palpitation, insomnia, libido absent. B.M.R. plus 16%. 
Complete blood count normal. B.P. 165/115. Physical examination 
essentially negative. Reveived 8 injections between Aug 31 
and September 26, 1931, dose gradually being increased to 300 
rat units per injection. This patient improved considerably. 
At the last examination, no other symptoms except palpitation 
were present. 
Case 8. A.M., aged 40, married, natural menopause, period 
in December, 1930, then Mar 4, 1931. She complained of flushes, 
sweats, pains in the elbow and feet and palpitation. Some insom-
nia. Physical examination was negative. B.M.R. minus 3%. Urin-
analysis negative. Blood count normal. This patient received 
7 injections of Theelin up to 200 rat units per injection from 
April 13 to :Uay 11, 1931. During which time she had two epi-
sodes of bleeding with complete alleviation of symptoms. As 
she was menstruating treatment was stopped. Theelin was prob-
ably a factor in causing the bleeding. Her symptoms aside from 
the time she was bleeding, were only slightly improved. 
Case 9. B. B;', age.d 44, married, natural menopause June;, 
1930. Symptoms appeared August, 1930, complained of flushes 
five times daily, headaches, joint pains in arms, leg and back, 
palpitation, psychie disturbances. Libido always absent. Phy-
sical examination negative. B.P. 156/90. B.I.R. minus 4%. 
Blood count except for 43% lymphocytes was normal. Urine 'neg-
ative. She received 15 injeetions of theelin up to 150 rat un-
its per injection. She showed some improvement. Flushes were 
reduced to 1 or 2 per day and other symptoms were also impro-
ved. She also reported increased libido. She then had a period 
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in April and another period in May. Treatment was discontinued 
as symptoms disappeared with the bleeding. 
Case 10. D. L. aged 44, married, natural menopause May, 
1929. Symptoms immediately afterward including moderate flu-
shes, some sweats,heatiache, stiffness in the joints, moderate 
palpitation, and insomnia. Libido present. Physical examin-
ation negative •. B.P. 160/90 weight 149. B.lf.R. minus 2 and 1%. 
This patient from the very beginning showed a marked globus 
hystericus with associated nervous symptoms which were entirely 
uninfluenced by treatment and were based on difficulties at 
home with her grown children. She r~e.'Ted 15 injections betw-
een Jan 12 and Feb 16, 1931, in increasing doses up to 125 rat 
units per injection. Improvement was marked, the only symptoms 
which persisted were joint pains and insomnia. Hysterical con-
dition was not affected, but patient responded very well to 
the interest sh~ in her case which probably influenced the 
improvement. 
Five cases of a.rtificial menopause are also reported, but 
since little or no relief was obtained it is not necessary to 
include them in detail. 
In two cases of kraurosis marked improvement was .noted 
using theelin in increasing doses. 
The following conclusions were noted: 
1. The evaluation of improvement or non-improvement in 
menopause symptoms as a basis for judgment of the efficacy of 
the preparation was found to be exceedingly difficult. 
2. Seven menopause cases of the 25 patients were de-
finitely improved, 3 with the reestablishment of menstruation. 
'he others were either unimproved or so slightly improved as 
to be negligible. 
3. Two patients with kraurosis on whom VUlvectomy 
had previously been performed showed marked improvement of the 
itching. 
4. In several cases of natural menopause, bleeding, 
possibly menstruation, followed the injection of theelin. 
5. The natural menopause seems to be more amenable to 
treatment than the artificial climax. 
6. Substitution of the female sex hormone alone soes 
not in all cases relieve the menopause syndrome. 
7. Other factors such as reduction of the quantity of 
the quantity of anterior pituitary hormone may improve the re-
sult. 
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Werner and Collier in studying the effect of theelin in-
jections, (200 rat units daily, for 28 days, 300 rat units daily 
the second 28 day period, and. 400 rat units daily the third 28 
day period) on castrated women, report the following results: 
1. Theelin restores the breasts and genital tract of 
women to apparently the normal sexu~l state after previous 
castration atrophy. 
2. Theelin produces changes in the atrophied endo-
metrium of castrated women that apprOXimate or equal the inter-
val changes found in the normal women at the time of ovulation. 
3. Theelin does not produce the pregravid changes 
in the endometrium of castrated women. 
4. The bleeding from the uterus of castrated women 
induced by theelin occurs from an endometrium approximating or 
equaling in development the interval changes found in the uter-
, us of. normal women. 
5. Theelin induces bleeding from the uterus of castr-
ated women qualitatively indistinguishable from menstruation 
"~ in normal women. 
6. This bleeding from the uterus of castrated women 
is accompanied by the subjective symptomatology usually exper-
ienced by normal women during menstruation. 
? Theelin relieves the subjective symptoms that occ-
ur in women following castration. 
S. Four ovariectomized women to whom large doses of 
theelin were given state that "libido was markedly increased." 
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9. Excessive doses of theelin were given to women intra-
muscularly over a period of from eighty nine to ninety three 
days without seeming discomfort, until a dosage of 300 to 400 
rat units daily was reached. 
It is evident that the marked difference in results ob-
tained by Geist and Spielman as compared with those obtained 
by Werner and Collier can be explained upon a basis of dosage. 
It is evident that castrates should require more hormone than 
those in which the ovaries are intact. 
In a recent st~dy of menopausal cases Sevringhaus calls 
to our attention these facts. In a series of 32 menopausal 
cases hot flashes occured in all, paresthesias in 16, insomnia 
in 19, and Jsychotic pictures in l? Obesity was found in 
only 13, and hypert~nsion in 10. Of this series 6 had artific-
ial climacteric produced by radiation or surgery, and there 
~~ were 3 patients with a spontaneous premature menopausal picture, 
possibly to be considered as ovarian insufficiency. 
The use of simple psychotherapeutic procedures and small 
~. doses of folliculin daily or oftener has been found very help-
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ful in the psychotic cases as well as in the simpler vasomotor 
types and the pseudothyrotoxic types. The value of frequent 
small doses rather than large doses at longer intervals in 
certain selected cases will be pointed out subsequently in this 
paper. 
Hamblen has reported 40 cases of menstrual disorder in 
which he used follicular and hypophyseal hormones. With the ex-
ception of several patients, to whom the yaginall pessaries in-
corporating the active hormone were supplied, the hormones 
were administered intramuscularly. When it was possible, a 
single hormone was used. In the majority of patients the hor-
mones were administered daily in doses of 100 rat units for two 
weeks with rest intervals of two weeks. Administration in this 
manner was repeated until results justified discontinuation. 
If it was possible, the hormones were administered during the 
inter-menstrual phase of the cycle. Sedatives were not dispen-
sed for the relief of subjective symptoms or combined in any 
way with these treatments. The only measures adjuvant to the 
endocrinal therapy were the correction of dietetic and hygien-
ic errors. 
There was no untoward reactions at the sites of injections. 
In a few instances patients received the anterior pituitary 
luteinizing hormone complained of slight local pain, 24 to 48 
hours after a certain injection, investigation usually revealed 
that the injection had been made too superficially. 
Again for the sake of illustration I shall include, in 
detail, the cases reported by Hamblen. 
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Case 1. Mrs J. T., aged 47, para 6-5-1, came to the dispen-
sary oomplaining of nervousness and headaches. During the past 
eighteen months her menstrual periods had gradually grown more 
scanty and more irregular. For the past 6 months she had ex-
perienced marked. vasomotor instability, characterized by faint-
ing spells, flashes, and emotional insta.bili ty., General phy-
sical examination revealed nothing of particular importance. 
Pelvic examination showed no pelvic abnormalities. She was 
given theelin, 100 rat units daily for two weeks, she noticed 
at the end of this treatment a disappearance of the emotional 
and nervous symptoms after two weeks rest, she reported a men-
strual period, which persisted and lasted for a week. She was 
given another two weeks treatment with theelin and the relief 
of the presenting symptoms continued. She had continued, how-
ever, to have a scant sanguinous discharge and, accordingly, 
was admitted to the hospital for a curretage of the uterus. 
The curettings were reported to show hyperplastic endometritis. 
Bleeding has not recurred since the operation and after two 
weeks or rest another series of theelin injections will be given. 
Case 2. Mrs W. S. Mc., aged 53 was seen in the dispensary 
to which she came with the symptoms of flashes, nervousness, 
and vertigo since the climacteric two years previously. She 
also complained of a low grade lumbar backache of an inconstant 
character. Physical examination and pelvic examination were 
essentially negative. The patient was slightly underweight. 
Laboratory findings we.re vii thin the range of normal. She was 
given theelin, 100 rat units daily for two"'weeks and then three 
times weekly for four weeks. After a week of treatment the 
patient was free of subjective symptoms. There was no return 
of menstruation. 
Case 3. Irs G.G., aged 46, para 6-0-6 had had scanty and 
irregular menstruation for the past year. The ss~ptoms which 
brought her to the gynecological clinic were extreme nervous-
ness, loss of appetite, gaseous eructations, and an inconstant 
lumbar backache. Physical examination disclosed no important 
abnormalities. The patient was slightly underweight. Pelvic 
examination revealed no pelvic disease. Laboratory findings 
were normal. She has been under treatment for the past 6 mo-
nths, during which time she has received theelin, 100 rat units 
three. times a week for two weeks with rest intervals of two 
weeks. She has reoeived relief from her symptoms, except the 
backache. The menstruation has become more regular b~t still 
remains scanty. 
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Case 4. Miss L.G., aged 47, was referred tp our clinic 
for diagnosis and treatment. She had had no menstruation for 
17 years. Her complaints were very varied, and included marked 
emotional instability, extreme nervousness, menifested by gross 
tremors, and many indefinite and inconstant pains. A diagnosis 
of involutional psychosis was made by the neurological consul-
tant. Her physical examination revealed nothing of consequence 
except marked vasomotor inata..bili ty, gross tremors of extremi-
ties and exaggerated reflexes. The wassermann test was negative. 
A trial of theelin was made. She was given 100 rat ~nits three 
times a week for eight weeks without any improvement or without 
any relief of symptoms. There was no return of menstruation. 
Case 5. Mrs A. I., aged 46 was referred to the clinic with 
symptoms of morning parietal headaches, flashes, emotional and 
vasomotor instability and marked melancholia. These symptoms 
had appeared during the last year and had been much intensified 
following the cessation of menstruation seven months previously. 
Physical examination revealed nothing of importance except a 
coarse tremor, refractive error of the eyes, well corrected 
with glasses, and a moderate obesity. Laboratory examinations 
were unimportant; She received theelin, 100 rat'units, daily 
for three weeks with rest intervals of one week for three months. 
The subjective symptoms, except occasional slight headaches, 
were, relieved after the first two weeks of treatment. There 
has been no return of menstruation. 
Case 6. Mrs B. S.t aged 40, para 2';'2;;;'5, was admitted to 
the hospital, complaining of an almost constant frontal head-
ache of approximately 6 months duration. During this time there 
had been a marked decrease in menstrual flow, associated with 
extreme nervousness, flashes, emotional instability and increased 
severity of the headaches. Blood pressure at time of admission 
was 210/160. Urinanalysis gave normal findings. Blood urea 
was 66 mgm. per 100 cc. Physical examination revealed a moderate 
enlargement of the heart with good regularity and no murmurs; 
eyes and sinuses were normal. Radiography of the sella tur-
cica revealed a slight hypoplasia. She was given a 1/4 grain 
hypodermic injection of morphine at the time of admission for 
the immediate relief of an almost unbearable headache. Subseq-
uent treatment consisted of a diet of moderately restricted 
protein and the administration of anterior pituitary lutein-
izing hormone 200 rat units daily for ten days. During this time 
the patient was confined to bed in the hospital. After two 
days of this treatment, the headache disappeared and during 
the last two days of the treatment there occured the first free 
and normal menstrual cycle the patient had had in six months, 
without the usual symptoms and with no headache. At the time 
of discharge from the hospital her blood pressure was 150/96 
and blood urea was 38 mgm. per 100 cc. She. is to receive further 
treatment. 
------_._._--------------------- ----------------------------- -.------~----------------
Case 7. I. R., aged 24, para 0-0-0, was referred to the 
dispensary for treatment of symptoms fcllowing a hysterectomy and 
bilatera~ salpingo-oophcrectomy in another hospital in July, 1930. 
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The patient complained of lcss cf apetite and weight, insomnia, failure 
to regain stre:ugth, and nervousness. Physical examination and labcr-
atory tests revealed no abnormalities. She was given theelin, 100 rat 
units daily for two weeks. She reported at the end of the treatment 
a eomplete relief of subjectiTe symptoms. She recently returned to the 
clinic after a month's rest from treatment and during this interval, 
had had no return of symptoms. 
Case 8. Mrs. J. G., aged 30, para 4-4-0, complained of nervousness, 
insomnia, flashes, and frequent attacks of vertigo. Her operative 
history included an operation elsewhere in 1927, at which time a left 
oophorectomy and right partial oophorectomy were done. She had received 
radiua therapy elsewhere in 1928 • th resulting cessation of menstrua-
tion. llier symptoms dated from that time. General examination and 
laboratory findings were unimportant, except for marked emotional and 
vasomotor instability. She received theelin, 100 rat units daily for 
two weeks. There was a reduction in the severity otthe symptoms and 
at the end of the treatment, there was a noticeable impro_ement of 
vasomotcr balance. She was unable to continue further treatment. 
Case 9. E. B., aged 29, was referred to the gynecological clinic 
for treatment. She had had a bilateral salpingo-oophorectomy in 1919. 
During the past two years, she had experiences flashes, vasomotor 
instability, characterized by nervousness, frequent sweats, and weak-
ness, and inconstant and ill-defined headaches. Physical examination 
and laboratory tests disclosed no important findings. She was given 
theelin, 100 rat units daily, for two weeks with relief of symptoms 
and disappearance of 'Vasomotor instability. At the end of two weeks, 
with rest from the treatment, she reports no return of symptoms. 
Case 10. Mrs. I.K.H., aged 44, was referred to the clinic for 
treatment. She complained of melancholia, emotional instability, 
flashes, and nervous instability. These symptoms dated from radium 
therapy elsewhere three years previous which resulted in the cessation 
of menstruation. General examination disclosed only moderate obesity. 
Laboratory findings were of no importance. She was given theelin, 100 
rat units daily, for three weeks. During the latter part of this 
treatment, she began to complain of pelvic cramps, associated with a 
sensation of fullness in this region and discontinued treatments in 
fear that menstruation was returning. She received an almost eomplete 
relief of subjective symptoms; menstruation did not result from her 
treatments. 
Case 11. Mrs. R. L., aged 45, para 6-0-6, complained of general 
malais:, dizzy spells and numbness in .the left flank, following an 
operatlon in August, 1930, whioh involved bilateral salpingo-oophor-
ectomy and supravaginal hysterectomy. General examination, pelvic 
examination, and laboratory studies gave normal findings. She was 
given vaginal pessaries, eaoh containing 50 rat units of follicular 
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hormone, one to be used each day. She continued this treatment for 
six weeks with almost complete relief of her symptoms, except for the 
numbness in her left flank. 
Case 12. E. H., aged 20, was referred to the gynecological clinic 
complaining of weakness', loss of titPeti te, pains in the muscles of the 
extremities and loss of weight, following an operation in December, 
,1930, which involved bilateral salpingo-oophorectomy. General physical 
examination revealid chronic infection of tonsils, malnutrition, and 
subnormal we!ght. The patient was of diminutive stature. Laboratory 
findings were within the range of normal. She was given theelin, 100 
rat units daily, for three weeks. There was an almost complete dis-
appearance of sympt~ms and she has gained five pounds. 
The remaining patients treated were those complaining of dysmen-
orrhea, etc., and do not have a place in this paper. 
Hamblen draws these conclusions from the results obtained in 
cases of the manopause (natural and artificial). "Thirteen patients 
with symptoms associated with the menopause were treated. The relief 
of subjective symptoms was excellent in eight patients and good in 
four. One patient received no benefit. There was no effect on men-
struation in ten cases; menorrhagia developed in one patient; and 
menstruation became more regular in two patients." 
Iazer and Ziserman in their recent work on the female sex hormone, 
have come to the conclusion that variations of clinical manifestations 
occurring in the climacterium are undoubtedly an expression of the 
combined effects produced by different stages of activity on the part 
of the glands of internal secretion. The endocrine pathogenesis, if 
it may thus be termed, is of a pluriglandular nature. The hyper-
sensitivity of the sympathetic nervous system, as evidenced by the 
vasomotor symptoms, may reasonably be attributed to the lack of female 
sex hormone. Although the symptoms strongly resemble the syndrome of 
hyperthyroidism, there is usually no evidence of an increased basal 
exchange. The administration of female sex hormone in these cases 
.".,..-. 
is the most rational and clinically the most effective method of 
controlling the distressing vasomotor symptoms. 
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The use of the female sex hormone by mouth has been a question 
of much debate. However, normally, the glands of internal secretion 
supply their products to the body as they are needed in small quantities 
and without demonstrable disturbances physiologically. In order to 
imitate nature, it is essential to administer glandular products in 
small, frequently repeated quantities. It is apparent that this is 
impossible when the products are given by the hypodermic needles. The 
oral administration of glandular products is ideal if the hormone is 
not affected by the gastric and intestinal secreti·ons and if it is 
pro,perlY absorbed. The efficacy of the oral administration of female 
sex hormone is still debatable. Large doses given hypodermically are 
eliminated rapidly through the urine and other channels before concen-
tration in the uterine mucosa is possible. Small doses at short 
intervals is ideal, but is hard to carry out unless given orally, the 
patient usually objecting strenueusly to more than one hypodermic 
injection daily. The administration of the hormone by means of 
vaginal pessaries is also unsatisfactory because they can usually be 
employed only before retiring. Furthermore, the gelatin mass almost 
invariably escapes from the vagina. 
Recent experimentation by Schoeller, Dohrn and Rohlweg tends to 
show that the peroral effect of follicular hormone preparations 
depends not only on the dose administered, but also on the presence 
of certain concomitant SUbstances which further the adsorption of 
the hormone. Using favorable concomitant substances (alcohol in 
various strengths) in suitable amounts, it was found that the relation-
ship between the effective subcutaneous and peroral doses was 1:4 
approximately. 
Bowman and Bender have recently studied the effect of female 
sex hormone in cases of involutional psychosis. 
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Severe cases of involutional melancholia were treated with 
ovarian hormone in the form of Squibb's amniotin. The method and 
amount of treatment varied. A careful study before and after treat-
ment was made of the blood pressure, basal metabolism, blood chemistry, 
and the galactose tolerance. 
Two cases showed a good social recovery. Three cases were 
unimproved and now show a chronic picture. Two cases died - one 
of anemia and broncho-pneumonia, and the other of carci ... a of the 
uterus. 
In giving amniotin, the possible restoration of the menstl:ua.l 
cycle was considered. The results were quite different. Except in 
case 1, where a very slight flow occurred on two occasions, the effect 
of treatment was to cause complete cessation of the menses. In three 
cases, there was menstruation up to the time of treatment, but none 
after treatment started. In case 2, menstruation continued for two 
months after treatment and then ceased. Case 6 had had a pan-hyster-
ectomy so that no changes were possible. Case 7 had had the menopause 
eleven years previously and treatment produced no effect. 
Very little change occurred in the blood chemistry during 
treatment. Where such changes did occur, they we~e usually in the 
direction of a more nonnal condition. However, some cases did show 
disturbances in weight, arterial tension, an increase in non-prGltein 
nitrogen not due to any apparent cardia-renal-vascular disease, a low 
blood cholesterol, disturbances in sugar curves, and low basal meta-
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boll sm. These may all be .avorably influenced by glandular therapy, 
especially the specific female sex hormone. Such therapeutic measures 
may improve the patient's general physical eondition, alleviate 
distressing symptoms, remove abnormal sensations which may be feeding 
delusional trends, shorten remissions, and in some instances are 
apparently associated with complete clinical recoveries. 
An intelligent application of such therapeutic measures speci-
fically directed against known symptoms and laboratory findings, may 
offer a valuable means of treating properly selected cases. Patients 
who show depression, indecision, delusional trends directed agaim t 
the environment, and without visceral disturbances and their associated 
hypochondriacal trends, will probably not be benefited by such 
treatment. Re-establisbment of menses should not be the aim. On the 
~. other hand, it may be possible to hasten a complete cessation of 
menses where the disturbance includes an annoying continuance of 
seanty, irregular menses or metrorrhagia of the menopause not due 
to uterine pathology. The combination of the sex hormone, especially 
wi th thyroid in cases of low metaboli sm, and wi th "];)i tui tary , obviously 
suggests itself. 
Iovak in a recent article is very enthusiastic over the recent 
advances made in endocrine therapy •. He states, "Kot so many years 
ago, the subject of endocrinology would have had to be approached 
almost apologetically, for the profession had, to use a slang 
expression, become ffed up' on the immense amount of misinformation 
and speculation emanating from the early enthusiasts on the subject. 
Such a cynical attitude is no longer justified, and indeed, is no 
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longer evident. The reason for this is obvious. Io longer is 
endocrinology a happy hunting ground for clinicians armed only with 
high-powered imaginations, or for oommercial pseudo-soientists with 
something to sell. The field is now being painstakingly worked by an 
army of scientific investigators." 
Novak points out that the older commeroial preparations of the 
ovary or corpus luteum, formerly so widely used, produce no objeotive 
results whatever, and that their subjecti~~ effects are very question-
able. Some observers have reported favorable results but the psychic 
factor associated with the menopause must be born in mind. 
Novak calls attention to the faot that theelin has no direct 
effect upon the ovary, its use being purely substitutional. Theelin 
can not produce the complete menstrual oycle; its use .hould be 
followed by progestin, but as yet no commercial preparation of 
progestin is available. Novak has used, however, the anterior 
pituitary luteinizing supstance prepared especially by Park, Davis, 
and Company, following injections of theelin, with a fair degree of 
success. This sUbstanoe is not available, however, at the present 
time. Theelin followed by the above preparation will produce menstru-
ation, but not at regular intervals, and requires monthly injeotions 
which are objected to rather strenuously by the patient. 
Marked improvement in cases of menopausal symptoms has been 
reported by ][ovak using theelin in doses of 50 to 100 rat units daily 
for at least six days. 
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Geist and Suielman have also carried out experiments using 
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amniotin as a therapeutic measure in the menopause. 
Amniotin (Squibb) is prepared from the fetal fluid of 
cattle by precipitation with alcohol, acetone, and ethyl ether. 
The resultant oil is further extracted with alcohol and ben-
zine and the resultant filtrate contains the amniotin which 
can be dissolved in water. The assay is carried out according 
to the technic of Doisy. The rats after the injection of the 
material must show fully cornified vaginal smears. 
This series consisted of 43 cases. In 10 there was no 
improvement, in 22 cases there was varying improvement, and 
in 11 eases the improvement was related to the appearance of 
vaginal bleeding after treatment. 
Amniotin was given in suppository form and by subcutaneeus 
or deep injections. The result was summarized as follows: 
In one group of cases amniotin seems to have influenced 
a return of the menstrual period with a temporary relief of 
symptoms; in other cases it caused a distinct alleviation of 
symptoms while the substance was exhibited, but the relief 
was not of a permanent nature. What influence the psychic 
effect of the treatment played is hard to evaluate. However, 
it is evident that the substitution of a single honnone that 
is not being produced by the individual, is not sufficient to 
prevent entirely the symptoms of the menopause, and it is cer-
tain that other factors are included in the problem of the 
menopause and its associated symptoms. 
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Clinical studies of supposed hypofunction of the ovaries 
are seriously handicapped by the lack of an objective and math-
ematical index of ovarian activity. The situation is analo-
gous to the observations made on hypothyroid syndromes before 
basal metabolic rates wer"e measured. But both clinical and 
fundamental scientific profit accrued from the more or less 
empirical association of certain symptoms with deficiency of 
thyroid secretion. It must not be forgotten that even tech-
nical1y perfect basal metabolic measurements sllowing low rates 
do not in every case demonstrate' a hypothyroidism. Clinical 
observation is just as necessary as before. The status of ob-
servations on the menopause and other menstrual irregularities 
id one of rather imperical grouptng based on the history and 
physical findings. Lacking specific tests for ovarian activity 
in the human female, the clinician must make diagnoses that 
are probable rather than certain. The closest approach to a 
specific test for the female sex hormone has been previously 
discussed. 
Severinghaus and Evans have also used amniotin in the 
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It appears that in this series of cases amniotin possesses 
the activity for the human female which the animal experiments 
'of Allen and Doisy would lead us to predict. In the hot flushes, 
insomnia, nervous instability, and headaches attributable to 
the menopause, artificial or spontaneous, amniotin has given 
very satisfactory relief. 
The manufacturers of this preparation (E.R. Squtbb and son) 
as well as others, have recommended the use of much larger 
doses than were employed. For the menopausal symptoms, doses 
of about 10 units daily are adequate, and may occasionally be 
excessive. Pessaries give results equally as good as hypoder-
mic injections. The occasion for the use of pessaries is the 
avoidance of the need of a hYPodermic. There are two difficul-
ties to be encountered however. One is that unmarried women 
are apt to abject to this method. The other is that except with 
very firm closure of the vaginal sphincter there is sufficient 
drainage after the melting of the gelatin to occasion discom-
fort and loss of material. This is preventable by the use of 
wool or cotton vaginal tampons. 
In 1864 Frankenhauser described a nerve supply of the uterus, 
and located a sympathetic nerve plexus lateral to and on each 
side of the cervix uteri in the transverse parametnium. At 
puberty. certain hypertrophic changes occur in these two large 
ganglia and regression changes likewise occur at the menopause 
independent of other sympathetic nerve ganglia. If we remove 
the uterus by a sub-total hysterectomy and leave the ovaries 
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the patient may, for a year or so, have no untoward symptoms, 
but later organized exudate and granulation tissue cause atrop-
hy chaBgesin the cervical ganglia, and ovarian deficiency is 
then evident. Experiments conducted by Kennedy show that 
regenerative changes occur in these ganglia after castration 
or menopause on the administration of sistomensin, which is 
a solutioh of oestrin in oil. According to Kearns climacteric 
neurosis improves greatly on the injection of sistomensin. 
The explanation of the biological behavior is expressed 
by regenerative changes in the mucosa of the uterus and also 
by checking immature developement in the corpus luteum. Sisto-
mensin will also supply the .corpus luteum hormone when it is 
decreased in the menopause. 
Present day treatment with the female sex hormone has been 
dealt with very thoroughly by Emmert of st Louis. According to 
him, if we sift the enormous and often conflicting literature 
on the female sex hormone we find only a few outstanding facts 
which seem to be definitely established. We know that the ovary 
remains in the dormant state from birth until the approach of 
puberty, and that during this first epoch in the life of the 
female it does not as yet produce any hormone in appreciable 
amounts. 
In contradistinction to the sex gland the other endocrine 
glands are active from the very beginning among these, the pit-
uitary gland, which is composed of two lobes, secretes different 
hormones in each lobe. It is the hormone produced in the anterior 
-
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lobe of the pituitary gland which has a fundamental influence 
upon the sex organs because it stimulates the ovary both as to 
growth and function. Under the influence of the anterior part 
of the hypophysis the follicles of the ovary ripen and secrete 
a hormone, which in turn causes a growth and proliferation of 
the endometrium in the uterus. After the rupture of the follicle 
there is established in the latter the corpus luteum which 
also produces a hormone that in its action is similiar to the' 
hormone contained in the follicle. 
We must, therefore bear in mind that the anterior lobe 
of pituitary is a sort of super-sex gland. Without the pitui-
tary gland there is no activity of the ovary, and without the 
ovary there is no activity of the uterus. 
Subnormal activity or hypofunction of the ovary is char-
acterized by the absence or scantiness of menstruation, fre-
quently accompanied by obesity and sterility. The exact class-
ification and grouping of these cases is extremely difficult. 
still more unsatisfactory is the present state of treatment. 
For many years therapy for all functional disorders consisted 
of the oral administration of the whole ovary or certain parts 
of it. Then it was realized that in any dried product there 
could be only a minute quantity of actual hormone, and this 
tiny amount was sure to be effectively destroyed by the gastric 
juice long before it could possibly be absorbed into the organ-
ism. Then extracts for intramuscular use appeaned on the mar-
ket, little more success was had with them. Claims made by 
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endocrine enthusiasts always stirred up hope, but the same re-
sults could not be produced in the hands of other men, and when 
men like Allen and Doisy, Frank, Graves and others clearly de-
monstrated that the commercial preparations contained only small 
amounts of hormones, it was realized that with our endocrine 
enthusiasts the wish had largely been father to the thought. 
Since that time the hormone has been definitely standard-
ized and has also been obtained in pure form. Hand in hand 
with this goes the isolation of the anterior pituitary hormone. 
These two discoveries mark a new milestone in the develope-
ment of organotherap~. From now on we shall be in a position 
to work with accurate amounts of a definitely determined sub-
stance. The anterior pituitary hormone shall be used to stim-
ulate the ovaries and while we are waiting for the ovaries to 
respond to the stimulus of the pituitary we shall inject the 
ovarian hormone so that the uterus !ray not be peprived of the 
essential need of the ovarian secretion. In other words in ovar-
ian hypofunction we shall carry out- a stimulation and a sub-
stitution therapy simultaneously. Where, however, there is no 
ovarian tissue left, as after castration, or where it is definite-
ly atrophied, as after menopause, there is obviously no need 
for pituitary hormone and only ovarian hormone is required 
tOo substitute for lack of secretion from the sex gland. 
Collip in his work on the human placenta found that it 
contained at least three distinct active principles, or hor-
mones. These three substances were alike in that all have 
been observed to be oestrogenic in the immature female rat. 
The first fraction was identified to be theelin. The active 
principle present in the second fraction (85 per cent alcohol 
solublej is very similar to theelin in its ultimate p sio-
logical effects. It is ineffective, however, in the 
and hence it may be concluded that it functions direc 
indirectly by stimulation of the intact ovary. It al 
ers from theelin in the degree to which it is effecti 
oral administration. The third fraction prepared fro the 
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alcohol insoluble material of the origional extract i similar 
to the other two in that it is oest-rogenic. It diffe s from 
the second or emmenin fraction on three main points: 1) it 
is ineffective by the oral ~oute; (2) it produces ora 
lutea in the immature rat coincident with induced rus; 
(3) it causes an increase in the rate of acc-
essory sex glands in the immature male. 
The two oestrogenic placental hormones theelin 
which have been described appear to be the counterpar s res-
pectively in placenta of prolan A (oestrogenic) and polan B 
(oestrogenic and luteinizing). 
, 
Collip treated 18 cases of the menopausal syndro e with 
emmenin, ,in 14 there was definite improvement. There 
improvement in castrates. Collip states; "Observatio 5 of this 
type of case lead one to conclude that the duration 0 this 
symptom complex is of prime importance, since no reli 
obtained in cases of long standing, whereas the symptoms were 
releived. for a time at least in certain cases where the con-
dition was of recent origin - that is, less than one year 
since the last menstrual flow. II 
A dose corresponding to 75 grams of placenta daily, given 
in divided doses in water or orange juice before meals, has 
been used in the majority of cases. There are individuals 
who do not tolerate the extract well. The cause of this could 
not be discovered; but j.n any case in which untoward symptoms, 
such as nausea or vertigo, have been observed, the dose was 
temporarily reduced until tolerance was acquired. 
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It was also found that during the course of treatment with 
the ovary stimulating hormone of the placenta certain patients 
have manifested symptoms of nausea, whilst others experienced 
some discomfort in the pelvic region. Others stated that they 
had experienced dreams of a vi~id and unusual character. Severe 
headache and mental depression have also occured. As a rule 
the patients voluntarily expressed a feeling of well-being in 
from four to five days after withdrawal of the extract. It is 
interesting to note that in view of the well established fact 
that the extract 1-s without effect on the oophorectomized: ro-
dent, clinically one cannot expect relief from menopausal sym-
ptoms after pan-hysterectomy. One such case was studied, with 
the anticipated failure to obtain any beneficial results. 
Collip has definitely established thru extensive exper-
imentation that the active principle obtained from the placenta 
"emmenin" i.s an ova~y stimulating hormone, probably pi tui tary 
in nature, and may be found effective in the activation of 
ovaries which are hypofunctional. Collip also discovered that 
the hormone is non-protein in character and is unaffected by 
digestive enzymes. It may therefore be administered orally. 
Now let us consider the secretion of the corpus luteum, 
and its possible relation to the menopause. 
In corners origional experiments on the corpus luteum he 
discovered that the alcoholic extracts of the corpus luteum, 
freed from phospholipids, contain a substance which when in-
jected into castrated adult female rabbits induces a character-
istic alteration of the endometrium identical with the pro-
gestational proliferation previously ,shown to be due to the 
presence of corpora lutea in the ovaries. A similiar effect 
is sometimes but not always produced in immature rabbits 8 to 
12 weeks old. Extracts of follicular fluid containing large 
amounts of theelin do not produce progestational proliferation, 
nor have extracts of human placenta given positive results. It 
appears, therefore, that the extracts of corpus luteum contain 
a special hormone which has for one of its functions the prep-
aration of the uterus for reception of embryos by inducing 
progestational proliferation of the endometrium. 
In the human menstrual cycle the progestin secreted by the 
active corpus luteum following ovulation normally prevents 
further ovulation and brings about the characteristic pre-
menstrual, secretory changes inthe endometrium, the ovarian 
follicle hormone, theelin bei.ng a necessary factor in this 
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process. The d.ecrease in progestin toward the end of the cycle 
is followed by menstruation. To account for the rise and ca-
dence of the corpus luteum and the concomitant variations in 
progestin it is necessary, for the present to postulate that 
when the graafian follicle reaches a certain stage in its 
growth under the influence of the gonad - stimulating hormone 
of the anterior hypophysis there takes place increased hypo-
physeal activity, with consezuent ovulation and luteinization. 
From the foregoing explanation it is evident that pro-
gestin prevents menstruation, or in other words is antagonis-
tic to the action of theelin, consequently, progestin would 
be indicated in cases of excessive flow, rather than cases of 
ammenorrhea, that are encountered in the menopause. Since 
however there is no commercial preparation of progestin avail-
able at the present time it is impossible to proove this point 
clinically. It has been prooven experimentally however that 
the hormone progestin inhibits the production of theelin and 
promotes its excretion. 
Glismann in studying cases of excessive hemorrhage, re-
commends the use of lipo-lutin, a potent lipoidal extract of 
corpus luteum, which is prepared by Parke, Davis and Company. 
This product has been found to be very useful in preventing 
abortion and excessive menstrual flow due to endocrine im-
balance, however it has been used in cases of post menopausal 
bleeding with an equal degree of success. The reason for this 
is readily seen, bearing the foregoing discussion in mind. 
Geist and Matus in a recent study of post-menopausal 
bleeding have found the cause to be chiefly benign and malig-
nant tumors, however tbey call attention to the importance 
of a study of the circulating blood and the tumor for the 
presence of hormones that may lead to a clearer understanding 
of the mechanism of the bleeding. 
We shall now consider the pituitary hormones as to their 
-possible therapeutic value in relation to the menopause. 
- N~1:,son in -recent experimentation observed 8 rats out of 
several hundred, that exhibited no oestrous change for at 
least five weeks. These animals were apparently in the best 
of health and quite normal in every respect except for their 
reproductive cycles. Age, inanition, and vitamin B deficiency 
could be ruled out. as causative factors, since the history 
of each animal was known. The possibility suggested itself 
that some factor in the normal pituitary gonadal relationship 
was inactive in these animals. 
After a period of anoestrous lasting from five to seven 
weeks one ovary and a portion of the uterus were removed in 
each instance. All material was fixed in Bouins and prepared 
for histological study. Two weeks was allowed for recovery. 
No oestrous changes occurred in any case. Seven of the animals 
were injected intramuscularly with one fresh anterior lobe 
(rat) each day. The 8th animal was given subcutaneous inject-
ions of an extract prepared from sheep pituitary. 
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In every instance oestrus occured on the third or fourth 
day following the instigation of treatment. The smear of 
flaky, cornified cells was typical in every respect of a normal 
oestrus and was preceded by the usual pro-oestrous picture. 
Subsequent autopsy revealed' the typical condition of oestrus. 
The rapid response of these non-cyclic females to anterior 
pituitary therapy seems t9 justify the initial supposition 
that some factor in their pituitary-gonadal relationship was 
inactive. We are reasonably certain at the present time, that, 
of the entire endocrine series the anterior hYPophysis is the 
only gland which is fundamentally concerned with the normal 
functioning of the gonads. In all probability other glands, 
notably the thyroid, have their roles in the maintenance of 
gonadal function, and disturbances in them may well be reflect-
ed in the gonads. However, all recent work has served to re-
legate them to a position of minor importance and has elevated 
the hypophysis to the major role. 
Nelson summarizes his work as follows: 
1. Eight adult female rats, which for at least five 
weeks had shown no oestrous changes in their vaginal smears, 
were given daily implants of anterior lobe, or daily injections 
of an extract prepared from anterior lobe material. 
2. Oestrous occured, in each instance, on the second 
or third day subsequent to the instigation of treatment. 
3. The ovaries and uteri prior to treatment presented 
a picture approximating that of dioestrus, while the remaining 
'/ 
52 
ovaries and uteri removed subsequent to the occurrence to the 
induced oestrus were either of oestrous or meta-oestrus character. 
4. When copulation was permitted at the time of induced 
oestrussllccessful pregnancies resulted. 
5. The pituitaries of these females were c;:tpable of pro-
moting precocious maturity in a young rat when introduced intra-
muscularly. 
6. No further oestrus changes could be demonstrated 
beyond the initial induced oestrus. 
7. It is eonclu4ed that the etiology of the aberrant 
ovarian behavior observed in these animals probably was some 
derangement of the normal hypophyseal-gonadal relationship, 
possibly the non-release of the gonadal stimulating hormone. 
In Hewitts work on extracts of the anterior pituitary, it 
was found possible to obtain extracts of anterior lobe of pit-
uitary glands having the following effects. 
(1) Growth promoting (filtered al~aline extracts) 
(2) Growth promoting and oestrous-inhibiting (unfiltered 
alkaline extracts) 
. (3) Premature maturity-and ripe follicle producing 
(acid extracts treated with kaolin, etc. ). 
It would seem therefore that three effects may be produced 
by extracts of anterior lobes. Evidence from histological, 
surgical, pathological and bio-chemical fields presents a strong 
case for the existence of hormones in the anterior pituitary 
lobe controlling growth and the female reproductive cycle. 
Two inferences may be drawn: Theoretically one is faced with 
-
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the presumption that the anterior lobe may control the ovarian 
cycle, and practically; one may hope for the establishment of 
replacement therapy indisturbances of growth and the female 
reproductive system. 
Evans. Meyer and Simpson in studying the relation of prolan 
to the anterior hypophyseal hormones arrived at these conclusions: 
1. Prolan does not easily repair the gonadal deficien-
cies of hypophysectomized animals. 
2. There is always a definite limit to the weiSh~ of 
the ovary which can be stimulated by prola,n in the immature 
rat within a definite time interval (100 hours). 
3. Hypophyseal hormones completely repair the gonadal 
deficiencies of hypophysectomized animals. 
r 4. The hypophyseal gonad-stimulating hormone does not 
show the limited effect on the-ovary of the in®ature rat found 
to be characteristic of prolan. The development of the ovary 
provoked by the hypophyseal hormone corresponds to the dose 
level. 
5. Only very small amounts of prolan, measured in terms 
of dry weight are required to give the minimal effect on the 
ovary. The amount of hypophyseal hormone needed to give a 
minimal effect is always much greate~. This is in contrast to 
the fact that higher doses of hypophyseal hormone provoke much 
greater ovary weights than can be obtained with any amount of 
prolan. 
54 
6. In earlier experiments the effect of prolan was in-
creased to the maximal effect obtainable by injecting hypophy-
seal sex hormone simply by combining prolan with small amounts 
of crude hypophyseal preparations, containing both gonad-stimul-
ating and growth hormones. The combination of prolan was made 
with doses of hypophyseal preparations which, given alone, 
were minimal or j~st sub-minimal in gonad-stimulating effect. 
Later prolan was added to the hypophyseal extract (growth hor-
mone) which, whenadministered alone, were devoid of any effect 
on the ovaries of immature animals and in this way also secured 
maximal effects. 
7. This activation effect is a specific reaction. If 
the hypophyseal extract is destroyed by heating, the combination 
of heated hypophyseal hormone with prolan is no longer any more 
effective than prolan alone. 
8. Low concentration of pure hypophyseal sex hormone 
combined with prolan do not result in activation effects. On 
the other hand sex free growth hormone is typically activated 
by prolan. 
Fluhmann published a collective review in 1931 dealing with 
the interrelationship of the anterior hypophysis and the ovaries. 
The majority of his conclusions have been included in this 
paper, however it may be of interest to include his summary of 
the use of ovary stimulating substances for therapeutic purposes. 
Of special importance to the practitioner is the possibility 
arising from experimentation on the anterior pituitary like sub-
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stances, of obtaining an ovary stimulating substance which may 
be employed for the treatment of amenorrhea, delayed menses, 
scanty menstruation and sterility. This work must be consider-
ed as still in the experimental stage but it is of interest that 
investigation along this line is proceeding hand in hand with 
the physiologic studies. The extracts at present in use thera-
peuticallyare either made from the urine of pregnant women, 
as for example, prolan, or from the placenta, as emmenin. 
Encouraging results in the treatment of so-called "hypo-
ovarian" conditions from the use of the German preparations 
prolan, pre-hormone and homhormone, have been reported by Zondek, 
and others. Zamkoff has also had very encouraging experiences 
from the use of urine from pregnant women, and good results 
from the injection of whole blood or blood serum from human 
pregnant donors have been reported by de-l./faortua and Esch. 
Zondek has employed prolan for the treatment of pelvic inflamm-
atory disease in view of his previous observation that the ad-
ministration of this extract causes a local increase of tempera-
ture, and believes that in association with bed-rest this method 
of therapy is highly commendable. This contention is support-
ed.by Montag, but on the other hand an adverse report has been 
given by Bauer and Lehfeldt, who in addition failed to obtain 
successful results in 10 cases of menstrual distuvbances att-
ributed to ovarian dysfunction. Fellner beiieves that feminin 
is preferable to anterior pituitary hormone from a therapeutic 
standpoint in view of the danger of injury to the ovaries. 
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Martin has successfully used prolan i~ high dos~s for patients 
with intractable menorrhagia, and suggests this as a possible 
means of producing a hormonal castration. 
The treatment of 135 cases of deranged ovarian function 
by the oral administration of the placental extract emmenin has 
been reported by Campbell and Collip. These authors note un-
satisfactory results in the treatment of primary amenorrhea, 
but find a high percentage of patients with improvement in cases 
of 2ndary amenorrhea, oligomenorrhea, dysmenorrhea, polymenorr-
hea, and menopausal symptoms. They have also obtained an areest 
of the bleeding in certain forms of menorrhagia and metorrhagia 
by the hypodermis administration of Collips "anterior-pituitary-
like" placental extract. 
CONCLUSIONS 
1. Tne menopause is a normal physiological process thru 
which all women must pass. The symptoms may be very severe 
in some cases while in others it may be as uneventful as any 
of the other necessary experiences to which the female economy 
is subj ected. 
2. The average age of cessation of menses is apprOXimately 
45 years 9 months. The average duration of symptoms is about 
two to two and a half years. 
3. All organs of the female reproductive system are sup-
jected to atrophic changes during and following the menopause. 
These changes associated with the usual symptoms are due to 
the withdrawal of the female sex hormone. 
4. Drugs are almost always necessary in addition to other 
therapeutic measures. Elixir triple bromides has been found 
to be very useful due to its depressing action on the va~omotor 
cen terse 
5. The older commercial preparations of whole ovary and 
corpus luteum formerly used have little or no potency, and are 
quickly destroyed by digestive enzymes. 
6. Theelin is of definite therapeutic value in the meno-
pause. Excessive doses (100-200 R.U. ) may be given without 
producing untoward symptoms. In the artificial menopause the 
dose must be large, since no ovarian function is present. In 
milder spontaneous cases the dose need not be so great, since 
some ovarian function is still present. In involutional states 
small doses are of definite value. The vaginal pessary has 
been unsatisfactory. Theelin is of value when administered 
orally, when accompanied by favorable concomitant substances. 
The ratio of subcutaneous and oral administration is 1:4. 
7. In all probabilities progestin is of value in cases of 
excessive flow, rather than in cases of amenorrhea. However it 
may be of value in certain cases of post menopausal bleeding. 
There is no satisfactory commercial preparation of progestin 
at the present time. 
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8. The anterior pituitary hormone is of value in some cases 
of menopausal symptoms. It is evident that pituitary would be 
of no value in the artificial menopause. In cases where some 
active ovarian tissue remains it would be indicated. The COIDm-
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ercial preparation antuitrin-S has not been in use long enough 
to draw any definite oonolusions. 
9. The symptom oomplex of the menopause is not due to a 
deorease or absenoe of only one hormone, the entire endoorine sys-
tem is involved. Consequently perfect results oannot be ob-
tained by substituting only one hormone. Properly oonduoted 
laboratory procedures as outlined, will give us muoh information 
as to the presenoe or absence of oertain hormones, having this 
information, the results should be much more enc.ouraging. How-
ever as yet the laboratory procedures are not perfeoted and the 
expense would make the prooedure impraotioal. There is also 
the question of oonoentration of extraots. At the present time 
it is necessary to injeot large amounts of material to get the 
desired effect, this amount will eventually be deoreased as it 
has been in various serums and antitoxins in use at the present 
time. 
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